A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).
Aparna R. Parikh(Massachusetts General Hospital), Theodore S. Hong(Massachusetts General Hospital), Lauren Matlack(Harvard University), Colin D. Weekes(Massachusetts General Hospital), Ryan B. Corcoran(Massachusetts General Hospital), Emily E. Van Seventer(Massachusetts General Hospital), David P. Ryan(East Carolina University), Jennifer Y. Wo(Massachusetts General Hospital), Bronwen Foreman(Harvard University), Lawrence S. Blaszkowsky(Brigham and Women's Hospital), Bruce J. Giantonio(Northwestern University), Jeffrey W. Clark(Massachusetts General Hospital), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Jill N. Allen(Harvard University), Lorraine C. Drapek(Harvard University), David T. Ting(Massachusetts General Hospital), Beow Y. Yeap(Harvard University), Leilana Ly(Harvard University)
Cited by 46
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k